Clinical trial
The Significance of the Vasopressin System of the Hemodynamics, Water Balance and Prognosis in Chronic Heart Failure
NCT01748331 is registered in ClinicalTrials.gov with Finn Gustafsson as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Significance of the Vasopressin System of the Hemodynamics, Water Balance and Prognosis in Chronic Heart Failure
- Lead sponsor
- Finn Gustafsson
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- November 30, 2012
- Completion date
- November 30, 2016
- Enrollment
- 40 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.